Page last updated: 2024-10-29

1-methyl-3-isobutylxanthine and Giant Cell Tumors

1-methyl-3-isobutylxanthine has been researched along with Giant Cell Tumors in 2 studies

1-Methyl-3-isobutylxanthine: A potent cyclic nucleotide phosphodiesterase inhibitor; due to this action, the compound increases cyclic AMP and cyclic GMP in tissue and thereby activates CYCLIC NUCLEOTIDE-REGULATED PROTEIN KINASES
3-isobutyl-1-methylxanthine : An oxopurine that is xanthine which is substituted at positions 1 and 3 by methyl and isobutyl groups, respectively.

Giant Cell Tumors: Tumors of bone tissue or synovial or other soft tissue characterized by the presence of giant cells. The most common are giant cell tumor of tendon sheath and GIANT CELL TUMOR OF BONE.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Goldring, SR2
Dayer, JM2
Rosenblatt, M1
Krane, SM1

Other Studies

2 other studies available for 1-methyl-3-isobutylxanthine and Giant Cell Tumors

ArticleYear
Factors regulating the response of cells cultured from human giant cell tumors of bone to parathyroid hormone.
    The Journal of clinical endocrinology and metabolism, 1981, Volume: 53, Issue:2

    Topics: 1-Methyl-3-isobutylxanthine; Bone Neoplasms; Cells, Cultured; Cyclic AMP; Dose-Response Relationship

1981
Regulation of hormone-induced cyclic AMP response to parathyroid hormone and prostaglandin E2 in cells cultured from human giant cell tumors of bone.
    Calcified tissue international, 1979, Volume: 29, Issue:3

    Topics: 1-Methyl-3-isobutylxanthine; Bone Neoplasms; Cells, Cultured; Cyclic AMP; Giant Cell Tumors; Humans;

1979